Home Cart Sign in  
Chemical Structure| 55778-02-4 Chemical Structure| 55778-02-4

Structure of WZ811
CAS No.: 55778-02-4

Chemical Structure| 55778-02-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

WZ811 is a small molecular and potency CXCR4 antagonist with EC50 of 0.3 nM.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of WZ811

CAS No. :55778-02-4
Formula : C18H18N4
M.W : 290.36
SMILES Code : C1(CNC2=NC=CC=C2)=CC=C(CNC3=NC=CC=C3)C=C1
MDL No. :MFCD18086914
InChI Key :KBVFRXIGQQRMEF-UHFFFAOYSA-N
Pubchem ID :11565518

Safety of WZ811

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of WZ811

GPCR

Isoform Comparison

Biological Activity

Target
  • CXCR4

    CXCR4, EC50:0.3 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
M-07e 1 μM 12 hours WZ811 significantly decreased the migration number of M-07e induced by BLM-treated lung tissues. PMC6733875
Medullary thyroid carcinoma cell line TT 100 nM and 1 μM 24 hours To investigate the effect of WZ811 on the invasiveness of medullary thyroid carcinoma cells, the results showed that WZ811 significantly reduced the invasiveness of cancer cells. PMC5729476
Human follicular thyroid carcinoma cell line TT2609-C02 1 µM and 100 nM 24 hours Investigate the effect of WZ811 on the invasiveness of TT2609-C02 cells, results showed WZ811 significantly reduced the number of invading cells PMC5868160
MELHO cells 10 µM WZ811 inhibited CXCR4, reduced osteotropism, and activated mTOR and p70-S6 cell signaling proteins. PMC10930675
1F5 RUNX2 KO cells 1.3 µg/mL and 2.6 µg/mL Restored RUNX2 expression increased the levels of CXCR4 and proteins associated with the metastatic process. PMC10930675

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice BLM-induced pulmonary fibrosis model intragastric administration 4 mg/kg once daily for 14 consecutive days WZ811 significantly attenuated BLM-induced pulmonary fibrosis, reduced the migration of CD41+ megakaryocytes, and decreased collagen deposition and TGF-β1 levels in lung tissue. PMC6733875

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.44mL

0.69mL

0.34mL

17.22mL

3.44mL

1.72mL

34.44mL

6.89mL

3.44mL

References

 

Historical Records

Categories